Search Results - "GLEICH, L. L"

COGNITIVE IMPAIRMENT, TECHNOPHILIA AND SACRAL NEUROMODULATION DEVICE UTILIZATION IN THE OLDER PATIENT POPULATION WITH OVERACTIVE BLADDER by Shenhar, C, Goldman, H, Booher, J, Gleich, L, Gill, B, Zillioux, J

Get full text

NOVEL PUDENDAL NEUROMODULATION TECHNIQUE USING ANATOMICAL LANDMARKS by Hoang Roberts, L, Shenhar, C, Booher, J, Gleich, L, Peters, K, Tracy Bee, M

Get full text

PELVIC FLOOR EXAM & TRIGGER POINT INJECTIONS: A CADAVERIC AND ANIMATED DEMONSTRATION by Booher, J, Shenhar, C, Hoang Roberts, L, Slopnick, E, Gleich, L

Get full text

NOVEL PUDENDAL NERVE BLOCK USING AN ANATOMICAL-LANDMARK GUIDED TRANSGLUTEAL APPROACH: A CADAVERIC FEASIBILITY STUDY by Hoang Roberts, L, Shenhar, C, Booher, J, Gleich, L, Peters, K, Bee, M

Get full text

Centrosome hyperamplification in human cancer : chromosome instability induced by p53 mutation and/or Mdm2 overexpression by CARROLL, P. E, OKUDA, M, HORN, H. F, BIDDINGER, P, STAMBROOK, P. J, GLEICH, L. L, LI, Y.-Q, TARAPORE, P, FUKASAWA, K

“…We have previously reported that loss of p53 tumor suppressor protein results in centrosome hyperamplification, which leads to aberrant mitosis and chromosome…”
Get full text

Esthesioneuroblastoma and Sinonasal Undifferentiated Carcinoma: Impact of Histological Grading and Clinical Staging on Survival and Prognosis by Christopher Miyamoto, R., Gleich, Lyon L., Biddinger, Paul W., Gluckman, Jack L.

“…Objectives Hyams proposed a histological grading system for esthesioneuroblastoma in which grade I tumors have an excellent prognosis and grade IV tumors are…”
Get full text

Anamorelin for the Treatment of Cancer Anorexia-Cachexia in Advanced NSCLC Patients: Results From ROMANA 1, a Pivotal Phase 3 Study by Bonomi, P, Temel, J, Currow, D, Fearon, K, Gleich, L, Yan, Y, Friend, J, Abernethy, A

Get full text

Gene Therapy for Head and Neck Cancer by Gleich, Lyon L.

“…Objectives/Hypothesis New treatment methods are needed for head and neck cancer to improve survival without increasing morbidity. Gene therapy is a potential…”
Get full text

Management Implications of Evaluating the N2 and N3 Neck After Organ Preservation Therapy by Strasser, Mark D., Gleich, Lyon L., Miller, Mary Ann, Saavedra, Harold I., Gluckman, Jack L.

“…Objectives/Hypothesis: To determine if metastatic squamous cell carcinoma with proliferative potential persists in N2 and N3 necks after conventional…”
Get full text

Centrosome Hyperamplification in Head and Neck Squamous Cell Carcinoma: A Potential Phenotypic Marker of Tumor Aggressiveness by Mark Gustafson, L., Gleich, Lyon L., Fukasawa, Kenji, Chadwell, Jon, Ann Miller, Mary, Stambrook, Peter J., Gluckman, Jack L.

“…Objectives/Hypothesis There is currently no single histological or genotypic marker that reliably predicts the biological behavior of head and neck squamous…”
Get full text

Survival, Function, and Quality of Life After Total Glossectomy by Ruhl, Charles M., Gleich, Lyon L., Gluckman, Jack L.

“…Advanced tongue cancer is associated with poor survival despite aggressive therapy. In an attempt at cure, many patients undergo total glossectomy, which…”
Get full text

Temporal bone carcinoma: contemporary perspectives in the skull base surgical era by Pensak, M L, Gleich, L L, Gluckman, J L, Shumrick, K A

“…Historically, malignant tumors that arose within the temporal bone or that intimately juxtaposed the petrous ridge portended an ominous prognosis. Perusal of…”
Get more information

Tumor angiogenesis as a prognostic indicator in T2-T4 oral cavity squamous cell carcinoma: A clinical-pathologic correlation by Gleich, Lyon L., Biddinger, Paul W., Duperier, Frank D., Gluckman, Jack L.

“…Background Tumor angiogenesis has been shown to correlate with tumor size, metastatic potential, and prognosis in breast and other cancers. Studies in head and…”
Get full text

Base-of-Tongue Cancer: Survival, Function, and Quality of Life After External-Beam Irradiation and Brachytherapy by Robertson, Matt L., Gleich, Lyon L., Barrett, William L., Gluckman, Jack L.

“…Objective Base‐of‐tongue cancer has traditionally been treated by surgical resection followed by radiation therapy. Primary radiation therapy with…”
Get full text

Silent gastroesophageal reflux disease in patients with pharyngolaryngeal cancer: Further results by Biacabe, Bernard, Gleich, Lyon L., Laccourreye, Ollivier, Hartl, Dana M., Bouchoucha, Michel, Brasnu, Daniel

“…Background Gastroesophageal reflux disease is associated with various head and neck manifestations. The aim of this retrospective study was to determine the…”
Get full text

The loss of heterozygosity in retinoblastoma and p53 suppressor genes as a prognostic indicator for head and neck cancer by Gleich, L L, Li, Y Q, Biddinger, P W, Gartside, P S, Stambrook, P J, Pavelic, Z P, Gluckman, J L

“…Inactivation of tumor suppressor genes, including p53 and retinoblastoma (Rb), are commonly found in all cancers, including head and neck squamous cell…”
Get more information

Dietary Antioxidant Intake in Patients at Risk for Second Primary Cancer by Steward, David L., Wiener, Frida, Gleich, Lyon L., Falciglia, Grace

“…Objectives To analyze dietary antioxidant intake for head and neck cancer patients at risk for development of second primary cancers. Study Design Prospective…”
Get full text

Tumor angiogenesis in T1 oral cavity squamous cell carcinoma: Role in predicting tumor aggressiveness by Gleich, Lyon L., Biddinger, Paul W., Pavelic, Zlatko P., Gluckman, Jack L.

“…Background Angiogenesis is necessary for tumor growth and metastasis. In breast and other cancers angiogenesis has been shown to correlate with tumor size,…”
Get full text

Surgical management of hard palate malignancies by TRUITT, THEODORE O., GLEICH, LYON L., HUNTRESS, GORDON P., GLUCKMAN, JACK L.

“…Objective: A variety of surgical procedures can be used to treat malignancies of the hard palate and inferior maxilla. This study was designed to evaluate the…”
Get full text

Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model by Blau, Sibel, Peguero, Julio Antonio, Moore, Halle C F, Anderson, Ian Churchill, Barve, Minal A, Cherian, Mathew Amprayil, Elkhanany, Ahmed, O'Sullivan, Ciara Catherine, Moreno-Aspitia, Alvaro, Plourde, Paul, Gleich, Lyon L, Riesen, Kendra, Ezzati, Ross, Degele, Meghan, Shulman, Megan, Stempf, Stephanie Dobson, Sachse, Laura, Iyer, Amrita A, Damodaran, Senthil, Cooney, Matthew M

“…There are numerous barriers to enrollment in oncology biomarker-driven studies. The ELAINE 2 study (ClinicalTrials.gov identifier: NCT04432454) is an…”
Get more information